In a phase 3 trial, Axpaxli, a tyrosine kinase inhibitor, achieved its superiority primary endpoint vs. aflibercept for the treatment of wet age-related macular degeneration, according to a press ...

Few SUVs are better known than the Ford Explorer. After the original made its debut in 1990, the Explorer has remained in production continuously, becoming a staple of family transportation. The ...